Blutmanagement in der Viszeralchirurgie

Zusammenfassung

Die Transfusion von Blut und Blutprodukten muss sich an bewährten Standards und Qualitätskriterien orientieren. Das Transfusionsgesetz stellt die Grundlage dazu sicher. Die bereits existierenden Leitlinien zur Transfusion müssen genutzt werden, um für die Chirurgie und speziell für die Viszeralchirurgie Ziele der Strategie für die Transfusion zu definieren. Dabei muss es ein Ziel sein, restriktiv mit der Ressource Blut zu verfahren. Kleiner werdende Spenderkollektive, weiterhin bestehende akute und chronische Risiken der Transfusion und die Kosten zwingen zu einer Optimierung in der Handhabung. Chirurgische Disziplinen sind die hauptsächlichen Verbraucher von Blut neben der Onkologie. Die Viszeralchirurgie hat dabei einen stetig steigenden Anteil, obgleich noch konkrete Daten fehlen. Die Chirurgie der Malignome und die Alterschirurgie haben hier den höchsten Stellenwert. Neben einer interdisziplinären Strategie bestehen bereits eine große Anzahl von technischen Verfahren und Hilfsmitteln, Blut im operativen Bereich optimaler anwenden zu können. Neben der gemeinsamen Definition strategischer Ziele können Algorithmen helfen, die Abläufe im Blutmanagement zu verbessern.

Abstract

The practice of blood transfusion must be complied with the standards of regulation and quality. The German transfusion law has defined the principles. Existing guidelines should contain criteria that make each transfusion necessary to be given easily justified without further investigation. But it should be clearly understood that guidelines serve as a means of evaluating transfusion practice not as transfusion indications. Actually there are growing numbers of reports of increased morbidity and mortality due to transfusion which is known as mediate inflammatory cytokines. The new safety measures, regulatory requirements, and the continual change in demographics there are less eligible donors resulting in concerns over adequacy of blood supply so far. To date most of the surgical societies do not deal with a specific management of blood and blood products. Beside the oncologists the surgeons are the second heavy users of all blood transfused. And the visceral surgeons have increasing needs in the stuff so far as the increasing rate of patients with malignancies and older patients are concerned. There are a variety of pharmacological agents and other technologies available to optimise the need for blood, to reduce the risk from transfusion, and to preserve the supply of the blood banks. Unfortunately there is a lack of evidence-based data not only in surgical literature. This review will give an overview on data to support the use of conservative transfusion practice and then to discuss the creation of strategies and how they can work. An algorithm how to deal with an effective practice of saving blood and transfusion will also been presented. One should consider that blood and blood products including the platelets and coagulation factors could become an increasing scarce resource in the future and for which to date adequate alternatives do not exist. So we as the main users should focus on prevention and strategic planning in our specific blood management.

Blutmanagement - Transfusionstrigger - blutsparende Maßnahmen

Blood management - transfusion trigger - saving blood

Literatur

• 1 Arbeitskreis Blut .Aktuelle Empfehlungen zur autologen Hämotherapie. Votum V 32, Mitteilung des Arbeitskreis Blut des Bundesministeriums für Gesundheit und Soziale Sicherung. 2005
• 2 The cost of blood: multidisciplinary consensus conference for standard methodology.  Transf Med Rev. 2005;  19 66-78
• 3 Hofmann A. Mikro- und makroökonomische Betrachtungen zu Kosten und Sparpotenzialen im europäischen Transfusionswesen. Vortrag, Wien 2002
• 4 Cantor S B, Hudson D V, Lichtiger B. et al . Costs of blood transfusion: a process-flow analysis.  J Clin Oncol. 1998;  16 2364-2370
• 5 Erhard J, Schlensak M, Friedrich J. Blutmanagement in der Chirurgie - eine Analyse.  Zentralbl Chir. 2003;  128 481-486
• 6 Gesetz zur Regelung des Transfusionswesens (Transfusionsgesetz - TFG). BGBl. 1998; 1752-1760
• 7 Müller N. Transfusionsgesetz in Deutschland - eine Bilanz.  Zentralbl Chir. 2003;  128 459-461
• 8 Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcome of anemia in surgery: a systemic review of the literature.  Am J Med. 2004;  116 58S-69S
• 9 Department of Public Health and Epidemiology .Health Survey of England. University of Birmingham Press, 2000
• 10 Dunne J R, Malone D, Tracy J K, Gannon C, Napolitana L M. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery.  J Surg Res. 2002;  102 237-244
• 11 Cappel M S, Goldberg E S. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: a significant trend of earlier cancer detection from 1982 through 1988 at a university hospital.  J Clin Gastroenterol. 1992;  14 227-235
• 12 M'Koma A E. Follow-up results of haematology data before and after restorative proctocolectomy: clnical outcome.  Dis Colon Rectum. 1994;  37 932-937
• 13 Benoist S, Panis Y, Pannegeon V. et al . Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients.  Surgery. 2001;  129 433-439
• 14 Kettelhack C, Hones C, Messinger D, Schlag P M. Randomized multicenter trial of the influence of recombinant human erythropoietin on intraoperative transfusion need in anemic patients undergoing right hemicolectomy for carcinoma.  Br J Surg. 1998;  85 63-67
• 15 Spahn D R. Benefits of red blood cell transfusion: where is the evidence?.  TATM. 1999;  1 6-10
• 16 Eagle K A, Berger P B, Calkins H. et al . ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery).  Circulation. 2002;  105 1257-1276
• 17 Jacob M, Brügger D, Conzen P, Becker B F, Finsterer U, Rehm M. Development and validation of a mathmatical algorithm for quantifying preoperative blood volume by means of the decrease in hematocrit resulting from acute normovolemic hemodilution.  Transfusion. 2005;  45 562-571
• 18 Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy.  Curr Med Res Opin. 1996;  13 465-478
• 19 Goodnough L T. Risks of blood transfusion.  Crit Care Med. 2003;  31 S678-S686
• 20 Goodnough L T, Shander A, Brecher M E. Transfusion medicine: looking to the future.  Lancet. 2003;  361 161-169
• 21 Semple J W. Leucodepletion and immune response mechanisms.  Vox Sang. 2004;  87 136-138
• 22 Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada.  Transfus Med Rev. 2003;  17 120-162
• 23 Heiss M M, Fraunberger P, Delanoff C. et al . Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.  Shock. 1997;  8 402-408
• 24 Marquet R L, Busch O R, Jeekel J, Heiss M M, Amato A C. Are allogeneic blood transfusions acceptable in elective sugery in colorectal carcinoma?.  Eur J Cancer. 1999;  35 352-360
• 25 Kooby D A, Stockman J, Ben-Porat L. et al . Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastasis.  Ann Surg. 2003;  217 860-870
• 26 Williamson L M, Lowe S, Love E M. et al . Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.  BMJ. 1999;  319 16-19
• 27 Helm R E, Rosengart T K, Gomez M. et al . Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion.  Ann Thorac Surg. 1998;  65 125-136
• 28 Carson J L, Duff A, Berlin J A. et al . Perioperative blood transfusion and postoperative mortality.  JAMA. 1998;  279 199-205
• 29 Carson J L, Noveck H, Berlin J A, Gould S A. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion.  Transfusion. 2002;  42 812-818
• 30 Herbert P C, Wells G, Blajchman M A. et al . A multicenter randomized, controlled clinical trial of transfusion requirements in critical care.  N Engl J Med. 1999;  340 409-417
• 31 Herbert P C, Yetisir E, Martin C. et al . Is low transfusion threshold safe in critically ill patients with cardiovascular disease?.  Crit Care Med. 2001;  29 227-234
• 32 Wu W C, Rathore S S, Wang Y, Radford M J, Krumholz H M. Blood transfusion in elderly patients with acute myocardial infarction.  N Engl J Med. 2001;  345 1230-1236
• 33 Consensus conference . Blood management surgical practice guidelines: Dallas, Texas, 12-14 January 1995.  Am J Surg. 1995;  170 S1-S73
• 34 Isbister J. Is the clinical significance of blood storage lesions underestimated?.  TATM. 2003;  5 356-362
• 35 Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion.  Transfus Med Rev. 2001;  15 91-107
• 36 Mansouri Taleghani B, Grossmann R, Reith H B, Wiebecke D, Thiede A. Fremdblutsparende Maßnahmen in der operativen Medizin.  Zentralbl Chir. 2000;  125 111-122
• 37 Goodnough L T. Autologe Blutgewinnung - akute normovolämische Hämodilution vs. präoperative Eigenblutspende.  Zentralbl Chir. 2003;  128 462-467
• 38 Carless P A, Anthony D M, Henry D A. Systematic review of the use of fibrin sealant to minimize perioperative allogenic blood transfusion.  Br J Surg. 2002;  89 695-703
• 39 Belghiti J, Noun R, Zante E. et al . Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study.  Ann Surg. 1996;  224 155-161
• 40 Catarci M, Carlini M, Gentileschi P, Santoro E. Major and minor injuries during the creation of pneumoperitoneum. A multicenter study on 12 919 cases.  Surg Endosc. 2001;  15 566-569